<DOC>
	<DOCNO>NCT01925222</DOCNO>
	<brief_summary>The purpose study ass direct effect ten-valent pneumococcal conjugate vaccine administer infant nasopharyngeal carriage 3 5 year age . These child vaccinate infancy cluster-randomized Finnish Invasive pneumococcal Disease ( FinIP ) Trial ( separate protocol report ClinicalTrials.gov Identifier : NCT00861380 ) 2009 2011 . Also indirect effect nasopharyngeal carriage assess vaccinee ' elder non-vaccinated sibling age 5 9 year .</brief_summary>
	<brief_title>Effects Pneumococcal Vaccine Nasopharyngeal Carriage</brief_title>
	<detailed_description>This study include cross-sectional sample nasopharyngeal oropharyngeal swab 2013 vaccinate unvaccinated child .</detailed_description>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>Inclusion Criteria FinIPvaccinated child : 1. age 3 5 year 2. enrol FinIP trial receive least one dose study vaccine infant vaccine schedule ( 3+1 2+1 ) 3. least one parent fluent Finnish 4. informed consent one parent Exclusion criterion FinIPvaccinated child 1 . PCV vaccination administer , randomize study vaccine 2. history antimicrobial treatment within 4 week ( child enrol later ) Inclusion criterion unvaccinated sibling 1. age 5 9 year 2. young sibling live household participate FinIP trial ( regardless vaccination schedule ) 3. least one parent fluent Finnish 4. informed consent one parent Exclusion criterion unvaccinated sibling 1 . PCV vaccination administer 2. history antimicrobial treatment within 4 week ( child enrol later )</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>9 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>